HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Ranjana Advani Selected Research

ISIS 3521

10/2005A phase I trial of aprinocarsen (ISIS 3521/LY900003), an antisense inhibitor of protein kinase C-alpha administered as a 24-hour weekly infusion schedule in patients with advanced cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Ranjana Advani Research Topics

Disease

26Hodgkin Disease (Hodgkin's Disease)
06/2023 - 03/2006
25Neoplasms (Cancer)
01/2024 - 11/2003
20Lymphoma (Lymphomas)
06/2023 - 07/2007
14Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
02/2022 - 06/2008
12Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2024 - 04/2004
7Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral)
10/2022 - 07/2013
6B-Cell Lymphoma (Lymphoma, B Cell)
06/2023 - 12/2008
6Anaplastic Large-Cell Lymphoma (Ki 1 Lymphoma)
10/2022 - 06/2012
6Waldenstrom Macroglobulinemia (Macroglobulinemia)
01/2021 - 06/2007
6Disease Progression
05/2019 - 11/2009
5Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
03/2016 - 09/2012
3Peripheral Nervous System Diseases (PNS Diseases)
01/2023 - 03/2014
2Cutaneous T-Cell Lymphoma (Lymphoma, T Cell, Cutaneous)
10/2022 - 03/2015
2Febrile Neutropenia
01/2022 - 06/2015
2Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
05/2019 - 01/2017
2Body Weight (Weight, Body)
11/2018 - 01/2015
2B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
02/2018 - 01/2015
2Sarcoma (Soft Tissue Sarcoma)
01/2018 - 12/2016
2T-Cell Lymphoma (Lymphoma, T Cell)
11/2017 - 03/2007
2Multiple Myeloma
03/2016 - 03/2009
1Immunoglobulin Light-chain Amyloidosis
01/2023
1Second Primary Neoplasms (Neoplasms, Second)
01/2022
1Cardiac Arrhythmias (Arrythmia)
01/2021
1Bone Marrow Diseases (Bone Marrow Disease)
01/2021
1Pathologic Complete Response
01/2020
1Enteropathy-Associated T-Cell Lymphoma
11/2017
1Paraproteinemias (Monoclonal Gammopathy)
03/2016
1Lymphoproliferative Disorders (Lymphoproliferative Disorder)
01/2016
1Neutropenia
06/2015

Drug/Important Bio-Agent (IBA)

17Doxorubicin (Adriamycin)FDA LinkGeneric
06/2023 - 01/2010
15Rituximab (Mabthera)FDA Link
02/2022 - 12/2008
13Brentuximab VedotinIBA
01/2023 - 01/2012
12Vincristine (Oncovin)FDA LinkGeneric
10/2022 - 01/2010
11Prednisone (Sone)FDA LinkGeneric
10/2022 - 01/2010
11Cyclophosphamide (Cytoxan)FDA LinkGeneric
10/2022 - 01/2010
8ibrutinibIBA
01/2024 - 01/2015
6Vinblastine (Vinblastine Sulfate)FDA Link
06/2023 - 02/2013
6Dacarbazine (DIC)FDA LinkGeneric
06/2023 - 02/2013
6Immunoconjugates (Immunoconjugate)IBA
01/2023 - 03/2015
6Etoposide (VP 16)FDA LinkGeneric
01/2021 - 03/2004
5Bleomycin (Blenoxane)FDA LinkGeneric
01/2022 - 02/2013
5dacetuzumabIBA
01/2015 - 03/2009
4Biomarkers (Surrogate Marker)IBA
06/2023 - 06/2011
4Monoclonal AntibodiesIBA
06/2014 - 06/2006
3Ferrosoferric Oxide (Magnetite)FDA Link
01/2018 - 12/2016
2AntigensIBA
01/2024 - 01/2009
2Phosphotransferases (Kinase)IBA
01/2024 - 01/2016
2Proteins (Proteins, Gene)FDA Link
01/2023 - 01/2004
2Immunoglobulin M (IgM)IBA
01/2021 - 03/2016
2RadiumIBA
01/2021 - 01/2021
2Bendamustine HydrochlorideFDA Link
01/2020 - 01/2018
2polatuzumab vedotinIBA
05/2019 - 06/2015
2Immune Checkpoint InhibitorsIBA
11/2018 - 11/2016
2Agammaglobulinaemia Tyrosine KinaseIBA
08/2016 - 01/2015
2Carboplatin (JM8)FDA LinkGeneric
01/2015 - 11/2003
2aprinocarsenIBA
10/2005 - 01/2004
2Antisense OligonucleotidesIBA
10/2005 - 01/2004
2Protein Kinase C-alphaIBA
10/2005 - 01/2004
1Toll-Like Receptor 9IBA
01/2024
1Transforming Growth Factors (Transforming Growth Factor)IBA
01/2024
1T-Cell Antigen Receptors (T-Cell Receptor)IBA
01/2024
1pembrolizumabIBA
06/2023
1cold agglutininsIBA
01/2023
1CryoglobulinsIBA
01/2023
16-bromo-2-naphthyl sulfate (BNS)IBA
01/2023
1Chimeric Antigen ReceptorsIBA
01/2023
1Ki-1 AntigenIBA
10/2022
13- (5- amino- 2- methyl- 4- oxoquinazolin- 3(4H)- yl)piperidine- 2,6- dioneIBA
02/2022
1spebrutinibIBA
02/2022
1CC-223IBA
02/2022
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2022
1Hemoglobins (Hemoglobin)IBA
01/2021
1Histone Deacetylase InhibitorsIBA
10/2020
1pinatuzumab vedotinIBA
05/2019
1magrolimabIBA
11/2018
1fenebrutinibIBA
02/2018
1Glucose (Dextrose)FDA LinkGeneric
01/2018
1GadoliniumIBA
01/2018
1Anaplastic Lymphoma KinaseIBA
11/2017
1ofatumumabFDA Link
01/2017
1Genetic Markers (Genetic Marker)IBA
01/2017
1Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
12/2016
1Immunomodulating AgentsIBA
11/2016
1AnthracyclinesIBA
03/2016
1FluorineIBA
01/2016
1belinostatIBA
03/2015

Therapy/Procedure

29Therapeutics
01/2023 - 04/2004
14Drug Therapy (Chemotherapy)
06/2021 - 03/2004
9Radiotherapy
12/2018 - 07/2007
3Salvage Therapy
01/2020 - 11/2014
3Combined Modality Therapy
12/2018 - 05/2011
3Stem Cell Transplantation
01/2018 - 06/2006
2Transplantation
01/2022 - 11/2017
2Immunotherapy
01/2018 - 06/2014
2Combination Drug Therapy (Combination Chemotherapy)
11/2013 - 06/2006
1Intravenous Injections
01/2018
1Cell Transplantation
11/2017
1Immunomodulation
11/2016
1Chemoradiotherapy
03/2016
1Palliative Care (Palliative Therapy)
01/2016